Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases

Annals of Surgery

Volumn 230, Issue 3, 1999, Pages 309-321

  Fong, Yuman ^a   Fortner, Joseph ^a   Sun, Ruth L ^a   Brennan, Murray F ^a   Blumgart, Leslie H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PARTIAL HEPATECTOMY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; TREATMENT OUTCOME; TUMOR VOLUME; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033504042     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199909000-00004     Document Type: Conference Paper

References (45)

1. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19:59-71.
2. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathological risk factors. Surgery 1994; 116:703-711.
3. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992; 216:492-505.
4. Nordlinger B, Pare R, Delva E, Quilichini M, Hannoun L, Huguet C. Hepatic resection for colorectal liver metastases. Ann Surg 1987; 205:256-263.
5. Hughes KS, Simons R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988; 103:278-288.
6. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938-946.
7. Jaffe BM, Donegan WL, Watson F, et al. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968; 127:1-11.
8. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver: I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969; 23:198-202.
9. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional vs. systemic continuous 5-FU chemotherapy in the treatment of colorectal metastases. Ann Surg 1987; 206:685-693.
10. Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [see comments]. Lancet 1998; 352:1413-1418.
11. Geller AI. A system, using neural cell lines, to characterize HSV-1 sectors containing genes which affect neuronal physiology, or neuronal promoters. J Neurosci Meth 1991; 36:91-103.
12. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie Cancer 1996; 77:1254-1262.
13. Goldsmith NA, Woodburne RT. The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet 1957; 105:310-318.
14. Couinaud C. Bases anatomiques des hepatectomies gauche et droite reglées. J Chirurgie 1954; 70:933-966.
15. Starzl TE, Bell RH, Heart RW, Putnam CW. Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet 1975; 141:429-438.
16. Matthews DE, Farewell VT. Understanding medical statistics. New York: Karger; 1990.
17. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972; 187-220.
18. Polk W, Fong Y, Karpeh M, Blumgart LH. A technique for the use of cryosurgery to assist hepatic resection. J Am Coll Surg 1995; 180: 171-176.
19. Lorenz M, Muller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 1998; 228:756-762.
20. Kemeny N, Huang Y, Cohen AM, et al. Randomized study of hepatic arterial infusion and systemic chemotherapy versus systemic chemotherapy alone as adjuvant treatment following resection of hepatic metastases from colorectal cancer [abstract]. Proceedings of the American Society of Clinical Oncology, Atlanta, GA, May 1999.
21. Kemeny N, Fong Y. Treatment of liver metastases. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR, eds. Cancer medicine. Baltimore: Williams & Wilkins; 1997:1939-1954.
22. Fleming ID, Cooper JS, Henson DE, et al. Manual for staging of cancer. 5th ed. Philadelphia: Lippincott-Raven; 1997.
23. Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 1989; 124:1021-1024.
24. Gilbert HA, Kagan AR. Metastases: incidence, detection, and evaluation without histologic confirmation. In: Weiss L. ed. Fundamental aspects of metastasis. Amsterdam: North Holland Publishing Co.; 1976:385-405.
25. Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978; 135:389-394.
26. Adson MA, Van Heerden JA, Adson MH, Wagner JS, Ilstrup DM. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984; 119:647-651.
27. Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 1984; 199:306-316.
28. Butler J, Attiyeh FF, Daly JM. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 1986; 162:109-113.
29. Pagana TJ. A new technique for hepatic infusional chemotherapy. Sem Surg Oncol 1986; 2:99-102.
30. Cobourn CS, Makowka L, Langer B, Taylor B, Falk R. Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet 1987; 165:239-246.
31. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer: competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990; 16: 360-365.
32. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozetti F. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991; 78:797-801.
33. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 1991; 214:107-113.
34. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110:13-29.
35. Cady B, Stone MD, McDermott WV Jr, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992; 127:561-569.
36. Cady B, Stone MD. The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol 1991; 18:399-406.
37. Belluco C, Guillem JG, Kemeny N, et al. p53 nuclear protein over-expression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases. J Clin Oncol 1996; 14: 2696-2701.
38. Lai DT, Fulham M, Stephen MS, et al. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 1996; 131:703-707.
39. Rivoire M, Yoshida K, Divgi C, Welt S, Cohen A, Sigurdson ER. Radioimmunodetection of hepatic metastases with gamma-detecting probe. Cancer Res 1990; 50:877s-879s.
40. August DA, Sugarbaker PH, Schneider PD. Lymphatic dissemination of hepatic metastases: implications for the follow-up and treatment of patients with colorectal cancer. Cancer 1985; 55:1490-1494.
41. Morris DL, Ross WB. Australian experience of cryoablation of liver tumors. Surg Oncol Clin North Am 1996; 5:391-397.
42. McGahan JP, Browning JP, Brock JM, et al. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25:267-270.
43. Kooby DA, Carew JF, Halterman MW, et al. Oncolytic viral therapy for human colorectal cancer and liver metastases using a multimutated herpes simplex virus type-1 (G207). FASEB J 1999 (in press).
44. Macapinlac HA, Kemeny N, Daghighian F, et al. Pilot clinical trial of 5-[125I]-Iodo-2′-deoxyuridine in the treatment of colorectal cancer metastatic to the liver. J Nucl Med 1996; 37:25S-32S.
45. Karpoff HM, D'Angelica M, Blair S, Brownlee MD, Federoff H, Fong Y. Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon. J Clin Invest 1997; 99:799-804.